ORIC
Oric Pharmaceuticals, Inc.
Key Financials
Net Income
$-129468000
↓ 1.3%
Operating Income
$-143004000
↓ 0.1%
Total Assets
$408.9M
↑ 49.2%
Total Liabilities
$24.5M
↓ 20.9%
EPS (Diluted)
$-1.47
↑ 19.7%
Shareholders' Equity
$384.4M
↑ 58.1%
Long-term Debt
$10.5M
N/A
Cash & Equivalents
$45.7M
↓ 23.1%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/15/2026 | View on SEC |
| SCHEDULE 13G | 5/15/2026 | View on SEC |
| SCHEDULE 13G/A | 5/12/2026 | View on SEC |
| 10-Q | 5/4/2026 | View on SEC |
| 8-K | 5/4/2026 | View on SEC |
| ARS | 4/28/2026 | View on SEC |
| DEFA14A | 4/28/2026 | View on SEC |
| DEF 14A | 4/28/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | ORIC |
| Company Name | Oric Pharmaceuticals, Inc. |
| CIK | 1796280 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (650) 388-5600 |